UVic research discovers a promising new way to detect lung cancer
Cancer Detectives by Suzanne Ahearne It’s good to have a fast metabolism if you’re talking about maintaining a healthy body weight. But cancer cells are also fast metabolizers. It’s what makes them more active and faster-growing than healthy cells. And it’s what makes them so dangerous. But their speed also makes them vulnerable. Long before […]
Biomark Attends Photonics West (California)
BioMark’s paper Surface Enhanced Raman Spectrometer (p-SERS) was on display at the Innovation Photonic Solutions (IPS) booth at the recent Photonics West conference in San Francisco, California. Pictured with BioMark’s Principal Engineer, Jim Elliott is IPS’s Sales Representative Tina Gong. BioMark was privileged to be part of IPS’s booth as IPS is the world leader […]
BioMark Brings New Life to Cancer Detection Technology
by Deborah Bacal from proactiveinvestors.com BioMark (CSE:BUX) has in its hands a diagnostic test that can detect cancer at an early stage, disrupting the current diagnostic market for the disease as we know it and making it easier for both patients and doctors alike. The metabolomics-based test consists of a single, one-shot application of Amantadine, […]
Equities.com Interview with Rashid Ahmed CEO
Cambridge’s 2015 Vancouver Resource Investment Conference in a Nutshell
By Gaalen Engen, Stockhouse.com The 2015 Vancouver Resource Investment Conference, hosted by Cambridge House International, is a regional event that attracts junior from a variety of resource sectors to network, promote and exchange experience in an exciting environment rife with investors, analysts and media.In past years, this event has been the premier meeting ground for the […]
BioMark CBC Radio Interview
BioMark’s CEO Rashid Ahmed was interviewed by Rick Cluff from CBC Radio’s The Early Edition. The full interview is available online at the CBC Radio One [1:20:00] http://www.cbc.ca/earlyedition/pastepisodes/
Global News: Richmond Company Develops Urine Cancer Test
Mon, Jan 5: A BC company is in the final stages of testing a simple new way of detecting cancer. Elaine Yong reports. Your browser does not support frames. Click here to view the frameless video.. Source: Global News http://globalnews.ca/video/1756747/richmond-company-develops-urine-cancer-test
BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite
We appreciate the opportunity speaking with BioMark Diagnostics at the equities.com Small-Cap Stars Conference at the NASDAQ MarketSite and to learn more about BioMark Diagnostics. Here is the link to your video interview: http://www.equities.com/media-gallery/384-brian-gusko-dir-of-corp-relations-for-biomark-diagnostics-bux?category_id=74
Biomark Diagnostics Develops Cancer Diagnostics Kit
Published by Canadian Investor on December 9, 2014 A newly listed company, Biomark Diagnostics, is making headlines with their cancer diagnostic technology, which is currently in Phase 3 clinical trials. The technology will enable patients to receive a non-invasive test for the diagnosis of many cancers. The Company’s patents and technology calls for the […]
Wolverton Securities advisor believes in biotechnology
Santo Sandhu, an investment advisor with Wolverton Securities, said he believes the best opportunities right now lie in biotechnology. That has led him to BioMark Diagnostics Inc., a Richmond B.C. company that is developing a cancer diagnostic system, using a known drug, which has already been approved by the U.S. Federal Drug Administration and Health […]
